Liver Allograft Antibody-Mediated Rejection: Reality or Myth?
Gastroenterologists, hepatologists, transplant surgeons, internists, advanced practice providers, fellows, residents, and medical students need to receive regular updates on recent advances in the field of Hepatology and Liver Transplantation. The series will highlight new developments in all areas related to liver diseases, changing selection criteria for transplantation, emerging transplantation techniques, and improved immunosuppressive therapies to minimize graft loss and other complications. The series aims to expand the knowledge of learners, promote current clinical and surgical best practices, enhance the quality of hepatology care, improve patient outcomes, and direct future research.
Physicians, medical students, fellows, residents, nurses, and other health professionals.
At the conclusion of the session, the participants should be able to:
Discuss the prevalence and risk of preformed donor-specific antibodies.
Recognize the prevalence of de novo donor-specific antibodies and describe how they affect transplant outcomes.
Review the criteria for diagnosing both acute and chronic antibody-mediated rejection.
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation